Add to ORKGThe relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn’s diseas
Item does not contain fulltextOBJECTIVES: To evaluate the effect of immunomodulators on formation of...
International audienceTumor necrosis factor inhibitors are effective in reducing inflammation in rhe...
Th e pharmacological management of Crohn ’ s disease (CD), an immune-mediated infl ammatory disorder...
Although low infliximab trough concentrations and antibodies to infliximab (ATI) are associated with...
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to...
The presence of antibodies towards infliximab (ATI) is associated with lower infliximab (IFX) trough...
The anti-TNF therapies infliximab and adalimumab have revolutionized the treatment of inflammatory b...
Background: Low anti-tumor necrosis factor α (TNFα) serum concentrations may result in lack of treat...
BACKGROUND Patients with Crohn's disease (CD) responding to anti-tumor necrosis factor (anti-TNF) s...
OBJECTIVES: The aim of this study was to evaluate the quantitative serum level of infliximab (IFX) a...
Background: The presence of antibodies towards infliximab (ATI) is associated with lower infliximab ...
Supplemental material, sj-docx-1-tag-10.1177_17562848211037849 for Dynamics of serum concentrations ...
Supplemental material, sj-docx-2-tag-10.1177_17562848211037849 for Dynamics of serum concentrations ...
BACKGROUND Patients with Crohn's disease (CD) responding to anti-tumor necrosis factor (anti-TNF)...
Antibodies toward infliximab are associated with low infliximab concentration at treatment initiatio...
Item does not contain fulltextOBJECTIVES: To evaluate the effect of immunomodulators on formation of...
International audienceTumor necrosis factor inhibitors are effective in reducing inflammation in rhe...
Th e pharmacological management of Crohn ’ s disease (CD), an immune-mediated infl ammatory disorder...
Although low infliximab trough concentrations and antibodies to infliximab (ATI) are associated with...
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to...
The presence of antibodies towards infliximab (ATI) is associated with lower infliximab (IFX) trough...
The anti-TNF therapies infliximab and adalimumab have revolutionized the treatment of inflammatory b...
Background: Low anti-tumor necrosis factor α (TNFα) serum concentrations may result in lack of treat...
BACKGROUND Patients with Crohn's disease (CD) responding to anti-tumor necrosis factor (anti-TNF) s...
OBJECTIVES: The aim of this study was to evaluate the quantitative serum level of infliximab (IFX) a...
Background: The presence of antibodies towards infliximab (ATI) is associated with lower infliximab ...
Supplemental material, sj-docx-1-tag-10.1177_17562848211037849 for Dynamics of serum concentrations ...
Supplemental material, sj-docx-2-tag-10.1177_17562848211037849 for Dynamics of serum concentrations ...
BACKGROUND Patients with Crohn's disease (CD) responding to anti-tumor necrosis factor (anti-TNF)...
Antibodies toward infliximab are associated with low infliximab concentration at treatment initiatio...
Item does not contain fulltextOBJECTIVES: To evaluate the effect of immunomodulators on formation of...
International audienceTumor necrosis factor inhibitors are effective in reducing inflammation in rhe...
Th e pharmacological management of Crohn ’ s disease (CD), an immune-mediated infl ammatory disorder...